Home Newsfeeds Oppenheimer Downgrades CinCor Pharma to Perform

Oppenheimer Downgrades CinCor Pharma to Perform

Oppenheimer analyst Jay Olson downgrades CinCor Pharma (NASDAQ:CINC) from Outperform to Perform.

byBenzinga Newsdesk

November 29, 2022

1 minute read

Oppenheimer analyst Jay Olson downgrades CinCor Pharma (NASDAQ:CINC) from Outperform to Perform.

Chemomab Presents Clinical Data From Investigator-Initiated Study Showing CM-101 Reduced Inflammatory And Fibrogenesis-Related Biomarkers In Patients With Severe Lung Injury Derived From Covid-19

By Benzinga Newsdesk

November 9, 9:12 AM

─New Findings Demonstrate CM-101's Anti-Inflammatory and Anti-Fibrotic Effects Are Highly Relevant to Inflammatory Lung Diseases─ TEL AVIV, Israel, Nov. 9, 2022 /PRNewswire/ -- Chemomab Therapeutics, Ltd.

CMMB

Stifel Reinstates Buy on KLA, Announces $505 Price Target

By Benzinga Newsdesk

January 18, 6:23 AM

Stifel analyst Brian Chin reinstates KLA (NASDAQ:KLAC) with a Buy and announces $505 price target.

KLAC

Jasper Therapeutics Announces Pricing Of $50M Underwritten Offering Of 3.9M Shares Of Common Stock At A Price Of $12.95/Share

By Benzinga Newsdesk

February 6, 10:01 AM

Jasper Therapeutics, Inc. (NASDAQ:JSPR) ("Jasper"), a clinical-stage biotechnology company focused on developing novel antibody therapies targeting c-Kit (CD117) to address diseases such as chronic spontaneous urticaria

JSPR

Snoop Dogg Teams Up With Edibles Producer To Launch New Snack, Here’s Where You Can Find It

By Jelena Martinovic

October 3, 11:32 AM

Snoop Dogg has teamed up with TSUMo Snacks, to launch Snazzle Os, a new line of cannabis-infused edibles, as part of their newly announced partnership.

MMNFF

Oppenheimer Downgrades CinCor Pharma to Perform

Related Posts

Chemomab Presents Clinical Data From Investigator-Initiated Study Showing CM-101 Reduced Inflammatory And Fibrogenesis-Related Biomarkers In Patients With Severe Lung Injury Derived From Covid-19

Stifel Reinstates Buy on KLA, Announces $505 Price Target

Jasper Therapeutics Announces Pricing Of $50M Underwritten Offering Of 3.9M Shares Of Common Stock At A Price Of $12.95/Share

Snoop Dogg Teams Up With Edibles Producer To Launch New Snack, Here’s Where You Can Find It